Mycotic Research

Click the links below to find more information:


Warm blanket, new heart for Port Gibson womanTomorrow. Every Day.Mississippi Miracles RadiothonLocal students among record number of graduates at UMMC's 57th Commencement
  • Presentations

    • Antifungal safety & efficacy applied to bone cement. P Sealy, JD Cleary, SW Chapman. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/IDSA 46th Annual Meeting. Washington, DC, Sept. 25, 2008.
    • Dalbavancin May Interact with Mannose Binding Lectin to Perpetuate Fungal Infection. 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/IDSA 46th Annual Meeting. Abstract #1518. Washington, DC, Sept. 25, 2008.
    • Cyanide altered risk of invasive fungal infections. D Legendre, JD Cleary, SW Chapman. Program and Abstracts of the Annual Fellowship Forum Meeting. Albany, NY, May 27, 2008.
    • Antifungal safety & efficacy applied to bone cement. P Sealy, JD Cleary, SW Chapman. Program and Abstracts of the Annual Fellowship Forum Meeting. Albany, NY, May 27, 2008.
    • Tumor necrosis factor- antagonists and the risk of invasive fungal infections. Moriau K, Cleary JD. Southeastern residency conference. University of Georgia. May 7, 2008.
    • Cyanide altered risk of invasive fungal infections. Legendre D, Cleary JD. Southeastern residency conference. University of Georgia. May 7, 2008.
    • Holy Grail Antifungal. Chapman SW, Cleary JD, Sullivan DS. 120th Annual Meeting of the American Clinical & Climatological Association. Charleston, SC, Oct. 19, 2007.
    • Glycopeptide Ligands Perpetuate Fungal Infection. Sealy P, Chapman SW, Cleary JD. Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, ILL, Sept. 19, 2007.
    • Antifungal Release from Cement Beads. Nguyen C, Cleary JD, Chapman SW. Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, ILL, Sept. 18, 2007.
    • Glycopeptide Ligands Perpetuate Fungal Infection. Sealy P, Chapman SW, Cleary JD. MADD Conference. Orlando, FL, May 15, 2007.
    • Antifungal Release from Cement Beads. Nguyen C, Cleary JD, Chapman SW. MADD Conference. Orlando, FL, May 15, 2007.
    • Glycopeptide Ligands Perpetuate Fungal Infection. Sealy P, Chapman SW, Cleary JD. Proceedings of the Second Annual Department of Medicine Research Day. Jackson, MS. April 19, 2007.
    • In Vitro Evaluation of Antifungal Release from Polymethylmethacrylate (PMMA)and Hydroxyapatite (HAC) Cement Beads. Nguyen C, Cleary JD. Southeastern residency conference. University of Georgia. May 7, 2007.
    • Comparison of Gene Expression in Malignant Gastric and Endometrial Tumors. Reddy SC, Kaelbling M, May W, Cleary J. Program and Abstracts of the 71st Mississippi Academy of Science Meeting. Biloxi, MS, Feb. 19, 2007.
    • Enzyme degradation of echinocandins. Cleary JD, Fang M, Kelley K, Chapman SW. Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, Sept. 18, 2006.
    • A Randomized, Double-Blind, Comparative Study of Amphotericin B Lipid Complex and Fluconazole versus Amphotericin B Lipid Complex Alone as Antifungal Treatment in Pediatric Patients with Invasive Candidiasis or Candidemia. Hill K, Islam S, Palmer A, Finley N, Cleary J. Southeastern residency conference. University of Georgia. May 5, 2006.
    • Candida albicans Pharmacogenomics of a Novel Antifungal Agent, NP17430. Cleary JD, Sullivan DC, Chapman SW, Walker L, Clark AM. Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, Dec. 18, 2005.
    • Epidemiologic Correlation Between Histoplasma Species Exposure and Stroke. JD Cleary, Pearson M, SW Chapman. Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, Dec. 18, 2005.
    • Improved Safety and Efficacy with Amphotericin B HP. JD Cleary, R Kramer, E Swiatlo, SW Chapman. Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, Dec. 18, 2005.
    • Differential Transcriptome Expression: Rhodanase and Cyanide Clearance. JD Cleary, KL Kelley, BA Chapman, DC Sullivan, SW Chapman. Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, Dec. 18, 2005.
    • Treatment and Prevention of Nematode Infections in Amazonian Indians. JD Cleary, RL Nolan, D Graham, SW Chapman. Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, Oct. 30, 2004.
    • Ant-mycotic Pharmacogenomics in Candidemia. JD Cleary, SW Chapman. Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, Nov. 2, 2004.
    • Anthropometric Assessments in Amazonian Indians: Mebendazole vs. Control. R Caskey, S Chapman, J Cleary. Dean's Summer Research Fellowship Program. Jackson, MS, Aug. 3, 2004.
    • Pharmacogenomics of Disseminated Candidemia. J Cleary, D Sullivan, D Wilkins, S Chapman. American Society of Microbiology Conference on Candida. Austin, TX. March 18, 2004.
    • Thrombocytosis Associated with Candidemia. AD Saathoff, S Elkins, SW Chapman, S McAllister, JD Cleary. Program and Abstracts of the 68th Mississippi Academy of Science Meeting. Biloxi, MS, Feb.19, 2004.
    • Voriconazole compared to a strategy of amphotericin B followed by fluconazole for treatment of candidaemia in non-neutropenic patients BJ Kullberg, P Pappas, M Ruhnke, C Viscoli, JD Cleary, E Rubinstein, LWP Church, JM Brown, JH Rex, F Hilton, I Oborska, M Hodges, HT Schlamm, J Sobel. ECCMID. Paris, France, 2004.
    • Pharmacodynamics/pharmacogenomics of Anti-mycotic Combinations. JD Cleary, SW Chapman. Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy. Atlanta, GA, Nov. 5, 2003.
    • Thrombocytosis Associated with Candidemia and its' Treatment. AD Saathoff, S Elkins, SW Chapman, JD Cleary. Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy. Atlanta, GA, Nov. 5, 2003.
    • Pharmacogenomic Signatures of the Anti-mycotic Terbinafine. JD Cleary, SW Chapman. Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL, Sept. 17, 2003.
    • Phase II Clinical Trial of Daclizumab / Amphotericin B combination. JD Cleary, R Gordon, SW Chapman. Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL, Sept. 27, 2003.
    • Pharmacogenomic responses in patients with disseminated candidiasis. JD Cleary, SW Chapman. Program and Abstracts of the ISHAM Meeting. San Antonio, TX, May 26, 2003.
    • Histoplasma capsulatum-induced differential expression of genes encoding coagulation factors and inflammatory cytokines in human umbilical vein endothelial cells. MM Pearson, JD Cleary, SW Chapman. Program and Abstracts of the Annual Fellowship Forum Meeting. Brainerd, MN, May 17, 2003.
    • Pharmacogenomics of Anti-mycotic Agents in Human Candida Infections. Cleary JD, Sullivan DC, Chapman SW. Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy. Albuquerque, NM, October 21st , 2002.
    • Impact of Desoxycholate (DOC) on Amphotericin B Induced Differential Gene Expression. Cleary JD, Chapman SW. Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy. Albuquerque, NM, Oct. 21, 2002.
    • Pharmacodynamics of antimycotic combinations. Cleary JD, deMestral JEL, Chapman SW. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA, Sept. 27, 2002.
    • Gene Profiling of Histoplasma Capsulatum Macrophage Interaction. Cleary JD, Sullivan DC, Chapman SW. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA, Sept. 27, 2002.
    • Genome-wide expression profiling of the response to polyene, pyrimidine, azole and echinocancin antifungal agents in Saccharomyces cerevisiae. Agarwal A, Rogers PD, Jacob MR, Barker KS, Cleary JD, Walker LA, Nagle DG, Clark AM. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA, Sept. 27, 2002.
    • Gene Expression profiling of histoplasma capsulatum/macrophage interaction. Sullivan DC, Cleary JD, Nalik R, Chapman SW. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA, Sept. 27, 2002.
    • Extended Spectrum B-lactamase-producing organisms at a university medical center. Shain C, Chapman SW, Cleary JD. Southeastern residency conference. University of Georgia. May 5, 2002.